Banerjee M - Search Results

1

Letter to Editor From Banerjee et al: "Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure".

Banerjee M, Maisnam I, Mukhopadhyay S. Banerjee M, et al. J Clin Endocrinol Metab. 2024 Jan 18;109(2):e873-e874. doi: 10.1210/clinem/dgad506. J Clin Endocrinol Metab. 2024. PMID: 37623277 No abstract available.

2

Jaundice and anaemia as presenting features of an incomplete autoimmune polyglandular syndrome type II.

Banerjee M, Mondal SK, Maisnam I, Mukherjee AK. Banerjee M, et al. BMJ Case Rep. 2019 Apr 8;12(4):e228490. doi: 10.1136/bcr-2018-228490. BMJ Case Rep. 2019. PMID: 30962212 Free PMC article.

3

Clinical Profile of Asymptomatic Bacteriuria in Type 2 Diabetes Mellitus: An Eastern India Perspective.

Banerjee M, Majumdar M, Kundu PK, Maisnam I, Mukherjee AK. Banerjee M, et al. Indian J Endocrinol Metab. 2019 May-Jun;23(3):293-297. doi: 10.4103/ijem.IJEM_674_18. Indian J Endocrinol Metab. 2019. PMID: 31641630 Free PMC article.

4

Endocrine Follow-up During Post-Acute COVID-19: Practical Recommendations Based on Available Clinical Evidence.

Pal R, Joshi A, Bhadada SK, Banerjee M, Vaikkakara S, Mukhopadhyay S. Pal R, et al. Among authors: banerjee m. Endocr Pract. 2022 Apr;28(4):425-432. doi: 10.1016/j.eprac.2022.02.003. Epub 2022 Feb 11. Endocr Pract. 2022. PMID: 35158058 Free PMC article. Review.

5

Can SGLT2 inhibitors prevent incident gout? A systematic review and meta-analysis.

Banerjee M, Pal R, Mukhopadhyay S. Banerjee M, et al. Acta Diabetol. 2022 Jun;59(6):783-791. doi: 10.1007/s00592-022-01866-3. Epub 2022 Mar 6. Acta Diabetol. 2022. PMID: 35249140

6

Letter to the Editor from Banerjee and Mondal: "Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline".

Banerjee M, Mondal S. Banerjee M, et al. J Clin Endocrinol Metab. 2022 Sep 28;107(10):e4272-e4273. doi: 10.1210/clinem/dgac478. J Clin Endocrinol Metab. 2022. PMID: 35962775 No abstract available.

7

Impact of Heart Failure History at Baseline on Cardiovascular Effects of GLP-1 Receptor Agonists in Type 2 Diabetes: a Meta-analysis.

Banerjee M, Maisnam I, Mukhopadhyay S. Banerjee M, et al. Cardiovasc Drugs Ther. 2024 Aug;38(4):739-746. doi: 10.1007/s10557-023-07432-5. Epub 2023 Jan 25. Cardiovasc Drugs Ther. 2024. PMID: 36696050

8

GLP-1 Receptor Agonists and Risk of Adverse Cerebrovascular Outcomes in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Banerjee M, Pal R, Mukhopadhyay S, Nair K. Banerjee M, et al. J Clin Endocrinol Metab. 2023 Jun 16;108(7):1806-1812. doi: 10.1210/clinem/dgad076. J Clin Endocrinol Metab. 2023. PMID: 36800286

9

SGLT2 inhibitors and cardiovascular outcomes in heart failure with mildly reduced and preserved ejection fraction: A systematic review and meta-analysis.

Banerjee M, Pal R, Nair K, Mukhopadhyay S. Banerjee M, et al. Indian Heart J. 2023 Mar-Apr;75(2):122-127. doi: 10.1016/j.ihj.2023.03.003. Epub 2023 Mar 11. Indian Heart J. 2023. PMID: 36914068 Free PMC article.

10

Gout.

Banerjee M, Mukhopadhyay S. Banerjee M, et al. N Engl J Med. 2023 Mar 30;388(13):e47. doi: 10.1056/NEJMc2216467. N Engl J Med. 2023. PMID: 36988610 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,477 results

Search Page

Filters